Today's Healthcare Pulse
FDA greenlights durvalumab combo for high‑risk bladder cancer
The FDA approved durvalumab (Imfinzi) combined with Bacillus Calmette‑Guerin for BCG‑naïve, high‑risk non‑muscle invasive bladder cancer. The POTOMAC trial enrolled 1,018 patients and showed a 32% reduction in disease recurrence risk (hazard ratio 0.68, p=0.015). Durvalumab is given at 1,500 mg IV every four weeks for up to 13 cycles.
Also developing:
By the numbers: Apogee Therapeutics raises $1.3B royalty financing
CMS Rolls Out ACCESS Model to Scale Safety‑Net Chronic Care Innovations
The Centers for Medicare & Medicaid Services (CMS) announced the ACCESS (Advancing Chronic Care with Effective, Scalable Solutions) Model, a 10‑year national demonstration beginning July 2026. The program validates and funds safety‑net health systems that use asynchronous electronic consultations to expand specialty access and improve chronic‑care outcomes.
AI in Healthcare Needs Proof, Not More FDA Oversight
An editorial by @HashemZikry @latimes @counselheatlh calling for more regulation of AI for patient use. Yes, there is "the staggering weight of unmet medical need," 1/3 Americans are using it to "diagnose symptoms and direct care," and states are moving...
Protecting Michigan’s Patients: The State’s Healthcare CISOs
Michigan’s healthcare ecosystem, spanning long‑term care, integrated health systems, academic centers, and statewide associations, is highlighted through a profile of its top CISOs. The feature showcases leaders from Ciena Healthcare, McLaren Health Care, the Michigan Health and Hospital Association, Corewell...
Prisoner Opens Fire at Chicago’s Swedish Hospital, Killing Officer, Wounding Another
A detainee receiving treatment at Endeavor Health’s Swedish Hospital opened fire Saturday, killing a 38‑year‑old officer and critically wounding a 57‑year‑old officer. The suspect was apprehended after a brief standoff, and the hospital remains closed while investigators assess security protocols.
Teen Vaping Quit Attempts Double Post-2019 Anti‑Vaping Campaigns
Teen vaping quit attempts nearly doubled after 2019, coinciding with widespread anti-vaping campaigns and extensive news coverage of lung injuries, marking a significant shift in adolescent vaping behavior in the United States. publichealth
Creative Biolabs Launches Integrated Microfluidic Platform for Neuron‑on‑a‑Chip and Cell Sorting
Creative Biolabs announced a new one‑stop microfluidic platform that merges neuron‑on‑a‑chip technology with cell‑sorting chips. The integrated service is designed to cut reagent waste, automate assays and deliver more physiologically relevant data for drug discovery, disease modeling and precision diagnostics.
FDA Grants Breakthrough Therapy Designation to Plixorafenib for BRAF‑Mutated Spinal Tumors
The U.S. Food and Drug Administration has granted breakthrough therapy designation to Plixorafenib, an investigational BRAF inhibitor targeting adult patients with BRAF V600E‑mutated high‑grade glioma of the spine. Early data show a 67% response rate, prompting faster regulatory review. The...
Editorial. Cover Point
The 80th National Sample Survey (2025 data) shows India’s health‑insurance coverage jumping to roughly 46% of rural and 44% of urban households, driven by schemes like Ayushman Bharat. At the same time, reported chronic ailments rose to 13.1%, reflecting better...
😷New Chapter 11 Bankruptcy Filing - John Fitzgibbon Memorial Hospital Inc.😷
On April 21, 2026, John Fitzgibbon Memorial Hospital Inc. and its affiliate Fitzgibbon Health Services filed Chapter 11 bankruptcy in the Western District of Missouri. The hospital operates a 60‑bed acute‑care facility, while FHS runs the 99‑bed The Living Center...
Sanofi's Dividend Streak Faces Dupixent Patent Cliff
A few weeks ago I published my deep dive on 🇫🇷 Sanofi $EPA:SAN 32 consecutive years of dividend growth. A true European Dividend Aristocrat 💪 Currently their main blockbuster Dupixent accounts for 36% of revenue, and compound patent protection expires in 2031....
This Week: Gene Editing Babies-Life Saving Science or Risky Business?
The debate over human germline editing intensified as two startups, Manhattan Genomics and Bootstrap Bio, folded after months of scrutiny, while Preventive announced a $30 million funding round backed by Coinbase CEO Brian Armstrong and OpenAI CEO Sam Altman. The controversy...
Scientific Superintelligence: The Deep Blue Moment
In 2026 AI systems are autonomously executing the full scientific method, from hypothesis generation to experimental iteration, at machine speed. Lila Sciences, backed by Flagship Pioneering, has built the first AI‑driven "Science Factories" that operate across biology, chemistry, materials and...
Popular Weight-Loss Drug May Cut Heart Attack Risk by 54%, New Studies Find
Recent studies show tirzepatide, the GLP‑1/GIP agonist behind Zepbound and Mounjaro, slashes major cardiovascular events by 54% in patients after angioplasty and cuts complications by roughly 30% after aortic valve replacement. The benefits persisted for at least a year, translating...
Driving Outcomes with a Digital Transportation Infrastructure
Healthcare consumers now demand the same speed and convenience they get in everyday life, and transportation barriers still prevent more than five million Americans from receiving timely care. Legacy non‑emergency medical transportation (NEMT) programs rely on phone queues and manual...
Midlife Fitness Proven to Boost Longevity and Health Span
A new JACC study from the Cooper Institute (April 22, 2026) followed nearly 25,000 adults for 30 years. As a medical school professor, I teach that the strongest longevity drug we have is not on a prescription pad. This study makes...
National Immunization Awareness Week
National Immunization Awareness Week highlights the critical role of vaccines in safeguarding public health and easing pressure on health systems. The campaign underscores both routine immunizations and ongoing preparedness initiatives. BIOTECanada’s Vaccine Industry Committee (VIC) showcases Canada’s leading vaccine manufacturers...
Healthcare’s Identity Crisis: Why A Single Prescription Requires Multiple Logins
Healthcare providers are hampered by fragmented identity systems that force patients, clinicians, insurers and other stakeholders to juggle multiple logins for routine tasks like prescription refills. The article highlights that the average 2025 data breach in the sector costs $7.42 million,...
Positive Affect Therapy Beats Traditional Depression Treatment in New JAMA Study
Researchers from SMU and UCLA reported that Positive Affect Treatment (PAT), a 15‑session program targeting joy and reward, produced greater clinical improvement than standard negative‑affect therapy in a randomized trial of 98 adults with severe anhedonia, depression and anxiety. The...
Thailand Pushes Therapeutic Luxury Tourism with $26 M Conference Revenue Goal
Thailand's Tourism Authority hosted the Amazing Thailand 2026 health and wellness conference on April 23, unveiling the "Thailand Excellence 2026" program and targeting over 929 million baht ($26 million) in revenue. The event underscored the country's $14 billion medical‑tourism sector, which grew 36.4%...
FDA Approves Eli Lilly's Foundayo, First New Oral Weight‑Loss Pill in Years
The U.S. Food and Drug Administration has approved Eli Lilly’s once‑daily oral weight‑loss pill, Foundayo, marking the first new molecular entity for obesity in years. Priced between $149 and $349 a month, the drug promises a simpler regimen that could broaden...
The Quiet Revolution Comes Full Circle: How CMS ACCESS Validates Safety-Net Innovation
CMS announced the ACCESS (Advancing Chronic Care with Effective, Scalable Solutions) Model, a ten‑year, national demonstration beginning July 2026 that validates the asynchronous e‑consult approaches pioneered by safety‑net health systems. The model introduces Outcome‑Aligned Payments, rewarding Medicare‑enrolled organizations for measurable...
Matteo Jorgenson Returns to Training a Week After Amstel Gold Crash
Visma-Lease a Bike announced that Matteo Jorgenson resumed training on rollers only a week after his Amstel Gold crash and collarbone surgery. The swift comeback forces the team to reshuffle its line‑up for Liège‑Bastogne‑Liège, highlighting the growing role of accelerated...
Sea Squirts’ Plasmalogens Show Promise in Reversing Aging Markers in Mice
Researchers from Xi’an Jiaotong‑Liverpool University, Stanford, Shanghai Jiao‑tong University and the Chinese Academy of Sciences reported that daily plasmalogen supplementation—derived from sea squirts—reversed key cognitive and physical aging markers in older female mice. The two‑month trial showed faster maze navigation...
WHO Pushes Supranational Vaccine Approval System, Sparking Regulatory Debate
The World Health Organization is advancing a supranational mechanism that would use its Emergency Use Listing (EUL) to influence vaccine approvals inside sovereign states. The proposal, highlighted by a recent analysis, cites Israel’s first test case and raises questions about...
Americans Fear Medicare, Medicaid Cuts After RFK Jr. Hearings
Health and Human Services Secretary Robert F. Kennedy Jr. defended President Trump’s 2027 budget that would slash $15.8 billion from HHS and set Medicaid on a path to lose $1 trillion by 2034. The testimony has ignited widespread fear among Medicare and...
Navigating Medical Training and Residency as a Female Plastic Surgeon
Dr. Smita Ramanadham reflects on her journey as the sole woman in a plastic surgery residency, emphasizing the pivotal role of male mentors and the absence of female role models. She highlights a systemic gap in training that overlooks billing,...
EMA Gives Redemplo (Plozasiran) Positive Opinion, Paving Way for EU Launch
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) issued a positive opinion for Redemplo (plozasiran), an RNA interference therapy for severe hypertriglyceridemia. The opinion triggers a 67‑day window for the European Commission to grant final marketing...
BMI Alone Misses Long‑term Heart Risk, Study Shows
A new Mass General Brigham study of 136,498 adults rewrites how we should screen cardiovascular risk. As a medical school professor, I teach that one lab number rarely tells the long-term story. This study (PLOS One, April 2026) shows the same...
Flickstop
Flickstop’s latest post showcases a chart ranking the top ten surgical robots worldwide for 2026, detailing each system’s rank, country of origin, manufacturer, and specialty. Earlier entries highlight a pandemic‑response robot designed for material handling, disinfection, temperature checks, and patrol...
‘Prior Authorization’ Has Become a Dirty Word in Healthcare, But It Might Be Medicare’s Smartest Path Forward
The CMS‑backed WISeR model launched a six‑state pilot on Jan. 1 to overhaul Medicare prior authorization using AI. It targets 17 procedures prone to fraud, waste and abuse, promising decisions in under three days versus the traditional 30‑day lag. Payment to...
Coercion Isn’t Care, and New Laws that Enforce Treatment and Confinement Are Dangerous
The Supreme Court of Canada reaffirmed the right to refuse unwanted medical treatment, but in the past year Alberta, Manitoba, British Columbia and Québec have passed laws that override this principle for people with addiction or mental‑health issues. Alberta’s 2025...
Letter to the Editor: Long Term Use of Proton Pump Inhibitors and Risk of Stomach Cancer: Population Based Case-Control Study...
A recent BMJ case‑control study across five Nordic countries reported no link between long‑term proton pump inhibitor (PPI) use and gastric non‑cardia adenocarcinoma. In a Letter to the Editor, Dr. Liping Kang challenges this conclusion, arguing that the study’s exposure...
Body Roundness Index Outperforms BMI in Predicting Depression Risk for Dementia Patients
Researchers published in the Journal of Health Psychology report that the Body Roundness Index (BRI) outperforms traditional BMI in predicting depressive symptoms among dementia patients. Analyzing 601 older adults, including 239 diagnosed with dementia, they found individuals in the highest...
Discovery of a Novel Vulnerability in Aggressive Lymphoma Could Change Future Therapy
Researchers at the University of Cologne’s Center for Molecular Medicine have identified the protein cFLIP as a critical driver of resistance in diffuse large B‑cell lymphoma (DLBCL), especially the ABC subtype. By overexpressing cFLIP, lymphoma cells block both intrinsic and...
British Researcher Exposes Fake Autism diagnosis...and Nobody Realizes It
British researcher Dame Uta Frith warned that autism diagnosis relies on behavioral criteria because no objective biomarker exists, making the process partly social. A blog post amplified her comments, suggesting the lack of a test applies to all mental disorders...
Where Commercial VBC Actually Lives Now
Commercial value‑based care (VBC) has moved from theory to operational reality, closing the long‑standing gap with Medicare. Primary‑source data from insurers such as Cigna, Elevance and Blue Shield show measurable cost reductions and improved outcomes in employer‑sponsored plans. The commercial VBC...
‘Science Fiction’: How Life-Saving Organs Are Being Kept Alive Outside the Body
Organ shortages have driven a shift from static cold storage to active preservation methods. Normothermic machine perfusion (NMP) keeps kidneys and livers metabolically active in a nutrient‑rich, oxygenated circuit, extending viable time outside the body. An Australian first double transplant...
Re: Matt Morgan: The Sticky Floor Test—Why I’m Returning to Face-to-Face Communication and M,ore on the Medium of Communication
In a letter to the BMJ, retired geriatrician Oscar Jolobe stresses that medical practice hinges on the messenger and the medium—particularly the hands‑on clinical exam. He decries headlines about medical students lacking stethoscope skills and warns that NHS hospitals are...
Cancer in 2026: The Era of “Invisible Recovery” And Body-Preserving Treatment
By 2026, oncology is shifting from survival‑only goals to an “invisible recovery” model that prioritizes preserving patients’ appearance, function, and emotional well‑being. Advances in precision imaging, robotic surgery, and AI‑driven diagnostics enable body‑preserving operations and earlier tumor detection, reducing the...
Why Cooking for Better Health Makes Dietary Changes Easier
The article argues that home cooking empowers patients to adopt healthier diets, especially by reducing sodium, because it provides tangible, visual cues that reinforce nutritional awareness. It draws on a personal story of a mother with hypertension and explains how...
Commercial Value-Based Care Has Quietly Turned Into a Real Messy, Multi-Payer Operating Layer Wedged Btwn Employer Cost Pressure, Payer Network...
Commercial value‑based care (VBC) has moved from theory to large‑scale operations, but its supporting infrastructure lags a decade behind Medicare. Major payers such as Cigna, Elevance, Blue Shield of California and Blue Cross NC now run hundreds of contracts covering...
Special Children in 2026: The Rise of “Ability-Focused Healthcare”
In 2026 the healthcare narrative for children with special needs has shifted from managing deficits to an ability‑focused model that highlights strengths and overall development. Early identification of developmental, learning, and sensory issues now triggers timely interventions during critical growth...
ScienceWorksHealth Details Mindfulness‑Based Trauma Protocols Across 42 States
ScienceWorksHealth’s website describes a suite of trauma‑treatment protocols that blend mindfulness‑based Acceptance and Commitment Therapy with CBT and EMDR, emphasizing high success rates and telehealth access in 42 states. The rollout underscores a broader shift toward evidence‑based, meditation‑informed mental‑health care.
Letter to the Editor: Standard Chemoradiotherapy with Concurrent and Adjuvant Camrelizumab in Patients with High Risk Nasopharyngeal Carcinoma: Multicentre, Randomised,...
A phase‑3 BMJ trial showed that adding the PD‑1 inhibitor camrelizumab to concurrent chemoradiotherapy and 17 cycles of adjuvant maintenance extended progression‑free survival in high‑risk nasopharyngeal carcinoma, but overall survival did not improve significantly (HR 0.59, P = 0.19) after a median 39.9‑month...
Scientists Identify CIRBP Protein That May Extend Human Lifespan to 200 Years
Scientists have isolated the cold‑inducible RNA‑binding protein (CIRBP) from bowhead whales and shown it dramatically improves DNA repair in human cells, raising the prospect of a 200‑year human lifespan. The finding fuels both excitement and caution across the anti‑aging and...
Consumer Biotech Poised to Dominate, Telehealth Captures Value
I’ve said this before: I believe consumer biotech will become the most compelling sub-sector within biotech - without question - and one of the most attractive investment opportunities overall. At its core, this category targets products that slow or reverse aging,...
Exploring Germany's Emerging Biotech Hubs in Tübingen and Heidelberg
All this week, I'm in Germany checking out the biotech scene in a couple of university towns: Tübingen and Heidelberg. Tune in.
WHO Flags Malaria in 80 Countries as Novartis Gains First Infant Treatment Prequalification
The World Health Organization confirmed that malaria remains endemic in 80 countries, accounting for 610,000 deaths in 2024, while Novartis secured WHO prequalification for Coartem Baby, the first malaria therapy specifically approved for newborns under 4.5 kg. Both developments underscore lingering...
Nesprin‑2 Protein Blocks Heart Cancer, May Aid Other Tumors
Wondered why we don’t hear about heart cancer? Contraction-sensing Nesprin-2 protein is discovered to prevent heart cancer By causing cells to pulse (or adding in Nespirin) we might be able to treat cancer in other organs 👏 @ScienceMagazine https://t.co/A8fOuw31N2
Switzerland Angers Italy by Claiming Costs of Treating Crans-Montana Fire Victims
Switzerland’s Federal Social Insurance Office announced it will invoice Italy for more than 100,000 Swiss francs (about $110,000) incurred treating four Italian nationals injured in the Crans‑Montana ski‑resort fire that killed 41 people. Italian Prime Minister Giorgia Meloni condemned the move...